Latest News

February 11, 2020

ArTara Therapeutics Appoints Blaine Davis as Chief Financial Officer

NEW YORK, February 11, 2020 – ArTara Therapeutics, Inc. (Nasdaq: […]
January 10, 2020

ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics

Shares of ArTara to commence trading on Nasdaq under new […]
December 19, 2019

ArTara Therapeutics Announces the Appointment of Richard Levy, M.D., and Gregory Sargen to its Board of Directors